Description
Talatisamine (12uM) and TEA (5mM) inhibits the enhanced I (K) caused by Abeta4 oligomers, attenuates cytotoxicity of Abeta oligomers by restoring cell viability and suppressing K (+) loss related apoptotic response. Talatisamine can therefore be considered as a leading compound worthy of further investigations